Preterm Birth And Prom Testing Industry Overview

The global preterm birth and PROM testing market size is expected to reach USD 2.45 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 8.3% from 2023 to 2030. The growing number of pregnant women, leading to an exponential rise in the number of preterm births is anticipated to drive market growth. Furthermore, the rise in the accessibility of POC will further drive the market.

Preterm births are not specific to a particular geography and have been recognized as a worldwide concern. The chance of such complication typically surges with a rising average age of pregnant women. Although over 60% of the births are found in Africa and South Asia. In lower-income nations, approximately 12% of children are born too early compared with 9% in higher-income nations. Within countries, poorer families have higher chances of premature birth. For instance, in India, many low-income states, such as Madhya Pradesh, Uttar Pradesh, and Bihar have low usage of public healthcare services for female infants. Despite the availability of free healthcare services, only around 41% of admissions to SNCUs are female infants  

Gather more insights about the market drivers, restrains and growth of the Preterm Birth And Prom Testing Market

In the light of COVID-19, the PROM testing market has taken a hit by disrupting the supply chain, and improper allocation of resources by companies during the ongoing pandemic affected the strategic initiatives in the market. COVID-19 infected pregnant women experienced a higher risk of developing complications such as preterm birth. Although some evidence suggests that vaccination has minimal or nearly no impact on pregnancy, however, there is no concrete research on it.  

Browse through Grand View Research's Medical Devices Industry Research Reports.

• The global prosthetics and orthotics market size was estimated at USD 6.56 billion in 2024 and is projected to grow at a CAGR of 4.4% from 2025 to 2030.
  
  
• The global fundus cameras market size was estimated at USD 370.9 million in 2024 and is expected to grow at a CAGR of 6.4% from 2025 to 2030.

Preterm Birth And PROM Testing Market Segmentation

Grand View Research has segmented the global preterm birth and PROM testing market based on test type, application, and region:

Preterm Birth And PROM Testing Type Outlook (Revenue, USD Million, 2018 - 2030)

• Pelvic exam
• Ultrasound
• Biochemical Markers
  • Interleukin (IL)-6
  • C-Reactive Protein (CRP)
  • IL-1, IL-2, IL-8, TNF-a
  • Corticotropin-Releasing Hormone (CRH)
  • Alpha-fetoprotein (AFP)
• Uterine Monitoring
• Nitazine Test
• Ferning Test
• Pooling
• PAMG-1 Immunoassay
• IGFBP Test
• Fetal Fibronectin (fFN)
• Others

Preterm Birth And PROM Testing Application Type Outlook (Revenue, USD Million, 2018 - 2030)

• PROM
• Preterm Labor
• Chorioamnionitis

Preterm Birth And PROM Testing Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Key Companies profiled:

• Qiagen N.V.
• Hologic, Inc.
• Cooper Surgical Inc.
• Abbott
• Medixbiochemica
• Sera Prognostics
• Clinical Innovations, LLC
• Biosynex
• NX Prenatal, Inc.
• IQ Products

Order a free sample PDF of the Preterm Birth And Prom Testing Market Intelligence Study, published by Grand View Research.